市場調查報告書
商品編碼
1463701
歐洲眼底相機市場預測至 2030 年 - 區域分析 - 按類型、攜帶性、應用和最終用戶Europe Fundus Cameras Market Forecast to 2030 - Regional Analysis - by Type, Portability, Application, and End User |
2022年歐洲眼底相機市場價值為1.8487億美元,預計到2030年將達到3.3755億美元;預計2022年至2030年CAGR為7.8%。
創新產品的推出推動歐洲眼底相機市場
醫療器材公司專注於新產品的開發和推出,並獲得相應監管機構的批准。以下提到了促進全球眼底市場的一些最新發展。
2021年10月,NIDEK株式會社宣布推出“Retina Scan Duo 2”,這是一種組合光學相干斷層掃描(OCT)和眼底攝影系統。新推出的產品具有使用者友善的功能,有助於提高眼部篩檢和臨床效率。 Retina Scan Duo 2 採用新穎的影像增強技術,可從單張影像產生高畫質影像,確保病患舒適度。 2023 年 1 月,領先的醫療設備和軟體解決方案提供商 Topcon Healthcare 宣布推出“NW500”,這是一款方便用戶使用的機器人眼底相機,可確保提供可靠且清晰的影像。新產品還可以簡化診斷實驗室的工作流程,增強患者體驗,並讓篩檢人員在光線充足的環境中取得視網膜影像。而且,他們不需要要求患者散瞳。此外,該產品還可以在三個傳統固視點(視盤、中心和黃斑)和用於週邊攝影的九個固視位置提供優質的彩色眼底影像。 2021年6月,Coburn Technologies宣布推出HFC-1免散瞳眼底相機,這是一款由Huvitz, Co., Ltd.製造的新型視網膜相機。快速、以及可靠的視網膜成像和測量。
歐洲眼底相機市場概況
根據《英國眼科雜誌》披露的統計數據,到 2050 年,導致不可逆失明和視力嚴重受損的主要原因——年齡相關性黃斑部病變將影響 7,700 萬歐洲人。根據美國眼科學會2023年報告,由於第2型糖尿病發生率上升,3%-4.1%的歐洲人受到糖尿病視網膜病變的影響。例如,英國,43.3%;瑞士,42.3%;波蘭,31.8%;德國佔實際發生率29.9%。此外,世界衛生組織 (WHO) 報告稱,蘇格蘭患糖尿病的人數有所增加。此外,英國是歐洲地區對所有12歲以上糖尿病患者進行全國篩檢最多的國家,共有900萬名患者,佔人口的6%。此外,歐洲地區不斷增加的產品批准進一步提高了美國眼底相機市場的採用率。根據記錄,2022 年 8 月,Formycon AG(“Formycon”)、Polpharma Biologics Group BV(“Polpharma Biologics”)和 Bioeq AG(“Bioeq”)宣布歐盟委員會(EU)授予“Ranivisio”的行銷授權( Ranivisio - Ranibizumab),Lucentis 的生物相似藥,旨在治療歐盟(EU) 的幾種嚴重視網膜疾病。上述因素將提高歐洲地區眼底相機的採用率,進而主導 2022-2030 年的市場成長。
歐洲眼底相機市場收入及 2030 年預測(百萬美元)
歐洲眼底相機市場區隔
歐洲眼底相機市場根據類型、攜帶性、應用、最終用戶和國家進行細分。
根據類型,歐洲眼底相機市場分為散瞳眼底相機、免散瞳眼底相機、混合眼底相機和ROP眼底相機。免散瞳眼底相機細分市場在 2022 年佔據最大市場。
基於攜帶性,歐洲眼底相機市場分為手持式和桌上型。 2022 年,桌面細分市場佔據了更大的市場。
根據應用,歐洲眼底相機市場分為糖尿病性視網膜病變、老年黃斑部病變、視網膜血管疾病等。 2022 年,糖尿病視網膜病變細分市場佔最大市場。
根據最終用戶,歐洲眼底相機市場分為醫院、眼科中心等。 2022 年,醫院細分市場佔據最大市場佔有率。
根據國家/地區,歐洲眼底相機市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022 年,德國在歐洲眼底相機市場佔有率中佔據主導地位。
Nikon Corp、Topcon Corp、NIDEK CO LTD、Canon Inc、Carl Zeiss AG、Visionix USA Inc、Kowa Co Ltd、CenterVue SpA、Volk Optical Inc 和 Digital Eye Center 是歐洲眼底相機市場的一些領先參與者。
表中的內容
The Europe fundus cameras market was valued at US$ 184.87 million in 2022 and is expected to reach US$ 337.55 million by 2030; it is estimated to grow at a CAGR of 7.8% from 2022 to 2030.
Launches of Innovative Products Fuel the Europe Fundus Cameras Market
Medical device companies focus on the development and launch of new products, along with obtaining approvals from corresponding regulatory bodies. A few of the recent developments fostering the global fundus market are mentioned below.
In October 2021, NIDEK CO., LTD. announced the launch of "Retina Scan Duo 2," a combined optical coherence tomography (OCT) and fundus camera system. The newly launched product aids in enhanced eye screening and clinical efficiency with user-friendly features. Retina Scan Duo 2 incorporates a novel image enhancement technique that generates an HD image from a single-frame image, ensuring great patient comfort. In January 2023, Topcon Healthcare, a leading provider of medical devices and software solutions, announced the launch of "NW500," a user-friendly, robotic fundus camera ensuring to deliver reliable and sharp-quality images. The new product also enables a streamlined workflow in diagnostic laboratories, enhancing the patient experience and allowing the screening personnel to acquire retinal images in well-lit settings. Moreover, they don't need to ask patients to dilate their eyes. Further, the product provides excellent-quality color fundus images across the three traditional fixation points (disc, center, and macula) and the nine fixation positions for peripheral photography. In June 2021, Coburn Technologies announced the launch of the HFC-1 Non-Mydriatic Fundus Camera, a new retinal camera manufactured by Huvitz, Co., Ltd. With a highly accurate autodetection technology, the products are intended to produce sharp, quick, and reliable retinal imaging and measurements.
Europe Fundus Cameras Market Overview
The leading cause of irreversible blindness and severely impaired eyesight-age-related macular degeneration will affect 77 million Europeans by 2050, as per the statistics revealed by the British Journal of Opthalmology. According to the American Academy of Ophthalmology 2023 report, 3%-4.1% of Europeans are affected by diabetic retinopathy owing to rising type 2 diabetes. For instance, the UK, 43.3%; Switzerland, 42.3%; Poland, 31.8%; and Germany accounting, 29.9%, accounting for actual incidence. Additionally, the World Health Organization (WHO) reports Scotland has faced an increase in the number of people suffering from diabetes. Moreover, the UK is the largest country in the Europe region with nationwide screening for all patients suffering from DM above the age of 12 years, comprising 9 million patients in total, accounting for 6% of the population. Further, rising product approvals in the European region further enhance the adoption of the US fundus camera market. For records, in August 2022, Formycon AG ("Formycon"), Polpharma Biologics Group BV ("Polpharma Biologics"), and Bioeq AG ("Bioeq") announced that the European Commission (EU) granted marketing authorization for "Ranivisio" (Ranivisio - Ranibizumab), biosimilar to Lucentis intended to treat several serious retinal diseases in the European Union (EU). Such aforementioned factors will enhance the adoption of fundus camera in the European region thereby dominating the market growth during 2022-2030.
Europe Fundus Cameras Market Revenue and Forecast to 2030 (US$ Million)
Europe Fundus Cameras Market Segmentation
The Europe fundus cameras market is segmented based on type, portability, application, end user, and country.
Based on type, the Europe fundus cameras market is segmented into mydriatic fundus camera, non-mydriatic fundus camera, hybrid fundus camera, and ROP fundus camera. The non-mydriatic fundus camera segment held the largest market share in 2022.
Based on portability, the Europe fundus cameras market is bifurcated into handheld and tabletop. The tabletop segment held a larger market share in 2022.
Based on application, the Europe fundus cameras market is segmented into diabetic retinopathy, age-related macular degeneration, retinal vascular disorders, and others. The diabetic retinopathy segment held the largest market share in 2022.
Based on end user, the Europe fundus cameras market is segmented into hospitals, ophthalmology centers, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Europe fundus cameras market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe fundus cameras market share in 2022.
Nikon Corp, Topcon Corp, NIDEK CO LTD, Canon Inc, Carl Zeiss AG, Visionix USA Inc, Kowa Co Ltd, CenterVue SpA, Volk Optical Inc, and Digital Eye Center are some of the leading players operating in the Europe fundus cameras market.
Table of Content